Treatment of Temporomandibular Joint Syndrome When Conservative Therapy Is Insufficient

Temporomandibular joint (TMJ) syndrome involves pain and dysfunction of the jaw joint and associated musculature. When first-line conservative measures do not provide adequate relief, or when severe acute exacerbations arise, a structured interventional approach is indicated.

Clinical Scenario

This protocol is directed at patients with TMJ syndrome whose conservative management has proven insufficient, or who require intervention during a severe acute exacerbation. Both the joint itself and the surrounding musculature may be targeted depending on the clinical picture.

Treatment Approach

The regimen for this scenario centres on targeted injections — administered either into the joint or into the surrounding musculature — with important guidance on when such interventions are appropriate and when their repetition is not. The full protocol specifies agents, sequencing, and clinical restrictions.

Instant Access to Structured Evidence-Based Regimens

References

If conservative therapies fail, or for severe acute exacerbations, intra-articular injection of local anesthetics or steroids may be used for TMJ syndrome.

However, repeated intra-articular injections are not recommended.

Intramuscular injection of onabotulinumtoxinA (BTX-A) has been advocated for management of myofascial pain.

View source ↗